The Food and Drug Administration has named a longtime regulator of cancer medications to lead the agency’s drug center.
FDA Commissioner Dr. Marty Makary joins 'Squawk Box' to discuss plans to speed up the approval of biosimilar generic drugs in ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Commissioner ...
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the agency's top officials said on ...